The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, vol.127, pp.2391-2405, 2016. ,
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera, Nature, vol.434, pp.1144-1148, 2005. ,
A gain-of-function mutation of JAK2 in myeloproliferative disorders, N. Engl. J. Med, vol.352, pp.1779-1790, 2005. ,
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders, Lancet, vol.365, pp.1054-1061, 2005. ,
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis, Cancer Cell, vol.7, pp.387-397, 2005. ,
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia, PLoS Med, 2006. ,
Somatic mutations of calreticulin in myeloproliferative neoplasms, N. Engl. J. Med, vol.369, pp.2379-2390, 2013. ,
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2, N. Engl. J. Med, vol.369, pp.2391-2405, 2013. ,
Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum, Biochem. J, vol.417, p.651, 2009. ,
Beyond lectins: The calnexin/calreticulin chaperone system of the endoplasmic reticulum, J. Cell Sci, vol.119, pp.615-623, 2006. ,
Calreticulin: One protein, one gene, many functions, Biochem. J, vol.344, pp.281-292, 1999. ,
N-Glycan-based ER molecular chaperone and protein quality control system: The Calnexin binding cycle, Traffic Cph. Den, vol.17, pp.308-326, 2016. ,
One step at a time: Endoplasmic reticulum-associated degradation, Nat. Rev. Mol. Cell Biol, vol.9, pp.944-957, 2008. ,
The mammalian unfolded protein response, Annu. Rev. Biochem, vol.74, pp.739-789, 2005. ,
Proteostasis control by the unfolded protein response, Nat. Cell Biol, vol.17, pp.829-838, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01175531
The impact of the endoplasmic reticulum protein-folding environment on cancer development, Nat. Rev. Cancer, vol.14, pp.581-597, 2014. ,
Endoplasmic reticulum stress-activated transcription factor ATF6? requires the disulfide isomerase PDIA5 to modulate chemoresistance, Mol. Cell. Biol, vol.34, pp.1839-1849, 2014. ,
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants, Blood, vol.127, pp.1325-1335, 2016. ,
Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms, Blood, vol.127, pp.1307-1316, 2016. ,
Calreticulin-mutant proteins induce megakaryocytic signaling to transform hematopoietic cells and undergo accelerated degradation and Golgi-mediated secretion, J. Hematol. Oncol, vol.9, p.45, 2016. ,
A novel signalling screen demonstrates that CALR mutations activate essential MAPK signalling and facilitate megakaryocyte differentiation, Leukemia, vol.31, pp.934-944, 2017. ,
Mutant calreticulin-expressing cells induce monocyte hyperreactivity through a paracrine mechanism, Am. J. Hematol, vol.91, pp.211-219, 2016. ,
Calnexin phosphorylation: Linking cytoplasmic signalling to endoplasmic reticulum lumenal functions, Semin. Cell Dev. Biol, vol.21, pp.486-490, 2010. ,
Calnexin phosphorylation attenuates the release of partially misfolded alpha1-antitrypsin to the secretory pathway, J. Biol. Chem, vol.284, pp.34570-34579, 2009. ,
Roscovitine is a proteostasis regulator that corrects the trafficking defect of F508del-CFTR by a CDK-independent mechanism, Br. J. Pharmacol, vol.171, pp.4831-4849, 2014. ,
Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis, Blood, vol.123, pp.123-133, 2014. ,
Genetic dissection of mammalian ERAD through comparative haploid and CRISPR forward genetic screens, Nat. Commun, 2016. ,
The JAK-STAT signaling pathway is differentially activated in CALR-positive compared with JAK2V617F-positive ET patients, Blood, vol.125, pp.1679-1681, 2015. ,
High throughput droplet single-cell Genotyping of Transcriptomes (GoT) reveals the cell identity dependency of the impact of somatic mutations, p.444687, 2018. ,
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants, Sci. Rep, vol.9, pp.1-14, 2019. ,
Phase I/II study of single-agent bortezomib for the treatment of patients with myelofibrosis. Clinical and biological effects of proteasome inhibition, Am. J. Hematol, vol.85, pp.616-619, 2010. ,
Bortezomib therapy in myelofibrosis: A phase II clinical trial, Leukemia, vol.22, pp.1636-1638, 2008. ,
Crucial role for endoplasmic reticulum stress during megakaryocyte maturation, Arterioscler. Thromb. Vasc. Biol, vol.33, pp.2750-2758, 2013. ,
Tumor-associated calreticulin variants functionally compromise the peptide loading complex and impair its recruitment of MHC-I, J. Biol. Chem, vol.293, pp.9555-9569, 2018. ,
Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants, Blood, vol.133, pp.2669-2681, 2019. ,
Circulating calreticulin is increased in myelofibrosis: Correlation with interleukin-6 plasma levels, bone marrow fibrosis, and splenomegaly, Mediators Inflamm, vol.5860657, 2016. ,
Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: Ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II), Hum. Mol. Genet, vol.16, pp.618-629, 2007. ,
Thrombopoietin receptor is required for the oncogenic function of CALR mutants, Leukemia, vol.30, pp.1759-1763, 2016. ,
A polypeptide binding conformation of calreticulin is induced by heat shock, calcium depletion, or by deletion of the C-terminal acidic region, Mol. Cell, vol.15, pp.913-923, 2004. ,
Defining the requirements for the pathogenic interaction between mutant calreticulin and MPL in MPN, Blood, vol.131, pp.782-786, 2018. ,
Stringent requirement for HRD1, SEL1L, and OS-9/XTP3-B for disposal of ERAD-LS substrates, J. Cell Biol, vol.188, pp.223-235, 2010. ,
EDEM2 initiates mammalian glycoprotein ERAD by catalyzing the first mannose trimming step, J. Cell Biol, vol.206, pp.347-356, 2014. ,
EDEM2 and OS-9 are required for ER-associated degradation of non-glycosylated sonic hedgehog, PLoS ONE, vol.9, 2014. ,
Characterization of an ERAD pathway for nonglycosylated BiP substrates, which require Herp, Mol. Cell, vol.28, pp.544-554, 2007. ,
Targeting the CALR interactome in myeloproliferative neoplasms, JCI Insight, vol.3, 2018. ,
Enhancement of proteasome activity by a small-molecule inhibitor of USP14, Nature, vol.467, pp.179-184, 2010. ,
Proteasome activation by small molecules, Cell Chem. Biol, vol.24, pp.725-736, 2017. ,
Alterations of EDEM1 functions enhance ATF6 pro-survival signaling, FEBS J, vol.285, pp.4146-4164, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01940302
Quantification of the mutant CALR allelic burden by digital PCR: Application to minimal residual disease evaluation after bone marrow transplantation, J. Mol. Diagn, vol.18, pp.68-74, 2016. ,
,